SIGA Technologies Declares $0.60 Special Dividend

Edgen Stock

·Mar 26 2026, 20:28

Share to

Share to

Copy link

Key Takeaways

SIGA Technologies announced a special cash dividend of $0.60 per share, signaling financial strength and a commitment to shareholder returns. The move underscores the company's solid balance sheet, supported by its role as a key supplier of biodefense countermeasures to governments globally.

Dividend Details: SIGA will pay a $0.60 special cash dividend per share on April 23, 2026, to shareholders of record as of April 7, 2026.
Consistent Returns: The payout matches the special dividend declared in April 2025, indicating a stable policy of returning capital to shareholders.
Strategic Rationale: Management links the dividend to a strong balance sheet and its ongoing strategy to supply governments with smallpox preparedness solutions during a period of heightened geopolitical volatility.

SIGA Technologies, Inc. (Nasdaq: SIGA) announced on March 26, 2026, that its board of directors has declared a special cash dividend of $0.60 per share. The dividend is scheduled to be paid on April 23, 2026, to all shareholders of record at the close of business on April 7, 2026. This move demonstrates a consistent approach to capital return, as the dividend amount is identical to the special dividend the company issued in April 2025.

CEO Cites Strong Balance Sheet and Biodefense Strategy

The decision to issue the dividend is a direct result of the company's financial health and strategic positioning. The payout reflects the commercial-stage pharmaceutical company's successful execution of its business model, which centers on partnerships with governments to prepare for potential health crises.

Today’s announcement of a special cash dividend reflects the strength of our balance sheet and focus on maximizing shareholder value. We remain committed to executing our strategy and working with governments to strengthen preparedness for a potential smallpox outbreak, which is even more critical in a time of heightened geopolitical volatility.

— Diem Nguyen, Chief Executive Officer.

This dividend signals confidence from management that its core business—supplying countermeasures for infectious diseases like smallpox—remains robust. The company's focus on providing essential biodefense products, such as its primary drug TPOXX®, provides a stable revenue stream that supports shareholder returns.

SIGA Announces $0.60 Per Share Special Dividend for April 2026

CEO Cites Strong Balance Sheet and Biodefense Strategy